Implementation of WHO guidelines on urine lateral flow LAM testing in high TB/HIV burden African countries

Despite disruptions caused by the COVID-19 pandemic, tuberculosis (TB) is still one of the top causes of death from an infectious disease, killing over 1.6 million people worldwide every year [1]. TB is curable with prompt detection and appropriate treatment, but it is estimated that over 30% of TB cases go undiagnosed annually [1]. Early diagnosis is crucial for optimal TB outcomes, especially among those most vulnerable to the disease such as people living with HIV (PLHIV), who experience higher rates of death from TB than those who are HIV negative [1]. Footnotes This manuscript has recently been accepted for publication in the European Respiratory Journal . It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.